A systematic review of the safety of probiotics (Q38176954)

30 August 2017

A systematic review of the safety of probiotics (English)

1 reference

30 August 2017

0 references

1 reference

5

1 reference

30 August 2017

Tina Didari

1

1 reference

30 August 2017

Sara Solki

series ordinal

2

1 reference

30 August 2017

Shilan Mozaffari

series ordinal

3

1 reference

30 August 2017

Shekoufeh Nikfar

series ordinal

4

1 reference

30 August 2017

language of work or name

English

0 references

publication date

3 January 2014

1 reference

Expert Opinion on Drug Safety

30 August 2017

1 reference

30 August 2017

13

1 reference

30 August 2017

227-239

1 reference

30 August 2017

2

1 reference

Functional foods and the immune system: a review.

30 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Study of adhesion and survival of lactobacilli and bifidobacteria on table olives with the aim of formulating a new probiotic food

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Product development of probiotics as biological drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics in clinical practice: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics, prebiotics, and synbiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Gastrointestinal microflora, food components and colon cancer prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Efficacy of probiotics in irritable bowel syndrome: a meta-analysis of randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Are probiotics effective in management of irritable bowel syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics use to treat irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

A meta-analysis on the efficacy of probiotics for maintenance of remission and prevention of clinical and endoscopic relapse in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Biochemical and pathological evidences on the benefit of a new biodegradable nanoparticles of probiotic extract in murine colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics and the gut microbiota in intestinal health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

A meta-analysis and systematic review on the effect of probiotics in acute diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Helping patients make informed choices about probiotics: a need for research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics and gut health: a special focus on liver diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Bifidobacteria can protect from enteropathogenic infection through production of acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics and health: an evidence-based review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics, prebiotics, energy balance, and obesity: mechanistic insights and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics in the development and treatment of allergic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Potential uses of probiotics in the neonate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Lactobacillus reuteri CRL1098 produces cobalamin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Fungemia with Saccharomyces cerevisiae in two newborns, only one of whom had been treated with ultra-levura

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Long-term safety and impact on infection rates of postnatal probiotic and prebiotic (synbiotic) treatment: randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Effects of probiotics on acquisition and spread of multiresistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

The probiotic Escherichia coli strain Nissle 1917 (EcN) stops acute diarrhoea in infants and toddlers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Outbreak of Saccharomyces cerevisiae Subtype boulardii Fungemia in Patients Neighboring Those Treated with a Probiotic Preparation of the Organism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Interaction between probiotic lactic acid bacteria and canine enteric pathogens: a risk factor for intestinal Enterococcus faecium colonization?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

VSL#3 probiotic upregulates intestinal mucosal alkaline sphingomyelinase and reduces inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Potential benefits of probiotics--main findings of an in-depth review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotic bacteria: safety, functional and technological properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Probiotic microbes: do they need to be alive to be beneficial?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Rapid determination of the bacterial composition of commercial probiotic products by terminal restriction fragment length polymorphism analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Diversity of the human intestinal microbial flora

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Enterococci as probiotics and their implications in food safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Enteral feeding of premature infants with Lactobacillus GG

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Clinical safety of Lactobacillus casei shirota as a probiotic in critically ill children

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Early administration of Bifidobacterium breve to preterm infants: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Effects of oral administration of bifidobacterium breve on fecal lactic acid and short-chain fatty acids in low birth weight infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Efficacy of an encapsulated probiotic Bifidobacterium infantis 35624 in women with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Prophylactic probiotics for prevention of necrotizing enterocolitis in very low birth weight newborns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Oral supplementation with probiotics in very-low-birth-weight preterm infants: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

A randomized placebo-controlled comparison of 2 prebiotic/probiotic combinations in preterm infants: impact on weight gain, intestinal microbiota, and fecal short-chain fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Oral probiotics prevent necrotizing enterocolitis in very low birth weight preterm infants: a multicenter, randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Enteral feeding of premature infants with Saccharomyces boulardii

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients. A multicenter, randomized, double-blind placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Effects of Saccharomyces boulardii on fecal short-chain fatty acids and microflora in patients on long-term total enteral nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

A randomized placebo-controlled trial of Saccharomyces boulardii in combination with standard antibiotics for Clostridium difficile disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Methaemoglobinaemia with concurrent blood isolation of Saccharomyces and Candida

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Saccharomyces boulardii fungaemia in an intensive care unit patient treated with caspofungin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Saccharomyces boulardii induced sepsis: successful therapy with voriconazole after treatment failure with fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Fungemia after oral treatment with Saccharomyces boulardii in a patient with multiple comorbidities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Possible role of catheters in Saccharomyces boulardii fungemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Seven cases of fungemia with Saccharomyces boulardii in critically ill patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Saccharomyces cerevisiae fungemia: an emerging infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Saccharomyces cerevisiae fungemia in an elderly patient with Clostridium difficile colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

Effect of synbiotic in constipated adult women - a randomized, double-blind, placebo-controlled study of clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.2014.872627

10.1517/14740338.2014.872627

21 January 2018

Identifiers

DOI

1 reference

30 August 2017

1 reference